Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

You are using software which is blocking our advertisements (adblocker).

As we provide the news for free, we are relying on revenues from our banners. So please disable your adblocker and reload the page to continue using this site.
Thanks!

Click here for a guide on disabling your adblocker.

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber

David Purschke joins NewLeaf Symbiotics as VP of Finance

David Purschke has been appointed as the new Vice President of Finance at NewLeaf Symbiotics.

Prior to joining NewLeaf Symbiotics, Purschke served as the Director of Finance at Spartech, LLC, where he successfully established and managed general accounting functions, guiding the company through audits and financial evaluations during its sale process. He also held leadership positions at Energizer Holdings, Inc., contributing to the company’s financial operations and strategic planning.

“We are excited to welcome David Purschke as our new VP of Finance,” said Brent Smith, President of NewLeaf Symbiotics. “With his extensive financial background and expertise, Purschke brings a vitally important skill set to our organization. As part of our leadership team, he will bring the rigor and discipline to help manage our rapid growth.”

“Joining NewLeaf Symbiotics is an exciting opportunity,” said David Purschke. “Their pioneering approach to sustainable agriculture aligns perfectly with my values. I look forward to leveraging my financial expertise to drive their initiatives and contribute to their leadership in the agricultural biotechnology industry.”

David Purschke’s appointment reflects NewLeaf Symbiotics’ commitment to attracting top talent and strengthening its financial capabilities. With Purschke’s financial leadership, NewLeaf Symbiotics is well-positioned to advance its growth initiatives and make a lasting impact in the agricultural biotechnology industry.

For more information:
NewLeaf Symbiotics
www.newleafsym.com

Publication date: